JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rutledge, C. O.
Right arrow Articles by Weiner, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rutledge, C. O.
Right arrow Articles by Weiner, N.
Journal of Pharmacology And Experimental Therapeutics, Vol. 157, Issue 2, 290-302, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF RESERPINE UPON THE SYNTHESIS OF NOREPINEPHRINE IN THE ISOLATED RABBIT HEART

Charles O. Rutledge 1 and Norman Weiner 1

1 Department of Pharmacology, Harvard Medical School, Boston, Mcssachusetts

In perfused hearts from reserpine-prctreated rabbits, the amounts of H3-norepinephrine and H3-3,4-dihydroxyphenyhethylamine (H3-dopamine) formed from H3-tyrosine were markedly lower than those formed in hearts of control animals. The effect was apparent as early as 15 min after the injection of reserpine and was dose-related. The effect of reserpine on the content of H3-amines preceded the depletion of endogenous norepinephrine content. R Reserpine produced the same effect whlen H3-dopa was perfused through the heart. When isolated atria from reserpine-pretreated rabbits were incubated with H3-dopamine, the amount of norepinephrine formed was much lower thlan that found when control atria were similarly incubated, and the metabolites of newly formed norepinephrine were not increased. The total formation of norepinephrine (norepinephrine plus norepinephrine metabolites) was inhibited in a dose-dependent manner. The metabolites of dopamine tended to increase in atrma Pretreated with reserpine. Isolated atria incubated with H3-norepinephrine metabolized the amine to 3,4-dihydroxyphenylglycol, 3-methoxy-4-hydroxyphenylglycol, 3,4-dihydroxymandehic acid and vanilmandelic acid. The predominant metabolite was dihdroxyphenylglycol. All of the metabolites of norepinephrine were increased in atria from reserpine-pretreated animals. These studies indicate that reserpine inhibits the synthesis of norepinephrine by inhibiting the uptake of its precursor, dopaminc, into the storage vesicle which contains the enzyme, dopamine-beta-hydroxylase. This action of reserpine also leads to reduced quantities of newly formed dopamine, since dopamine, which is not taken up and stored, is more rapidly metabolized, primarily by monoamine oxidase.

Submitted on October 3, 1966
Accepted on January 25, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.